Global and United States Rare Disease Drug Market Insights, Forecast to 2026

Publisher Name :
Date: 16-Oct-2020
No. of pages: 142
Inquire Before Buying

Rare Disease Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Rare Disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Rare Disease Drug market is segmented into

- Above 1‰

- 0.65‰?1‰

- Below 0.1‰

Segment by Application, the Rare Disease Drug market is segmented into

- Hospital Pharmacies

- Speciality Pharmacies

- Retail pharmacies

- Others

Regional and Country-level Analysis

The Rare Disease Drug market is analysed and market size information is provided by regions (countries).

The key regions covered in the Rare Disease Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Rare Disease Drug Market Share Analysis

Rare Disease Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Rare Disease Drug business, the date to enter into the Rare Disease Drug market, Rare Disease Drug product introduction, recent developments, etc.

The major vendors covered:

- Novartis AG

- Bristol-Myers Squibb Company

- Celgene Corporation

- F. Hoffmann-La Roche Ltd.

- Pfizer, Inc.

- Sanofi S.A.

- Alexion Pharmaceuticals, Inc.

- Eli Lilly and Company

- Novo Nordisk A/S

- AstraZeneca

- Eisai Co., Ltd.

- Daiichi Sankyo Company Limited

- Bayer AG

- GlaxoSmithKline

- Merck & Co., Inc.

- Johnson & Johnson

- Biogen, Inc.

- Takeda

- Amgen, Inc.

- Deciphera

- Atara Biotherapeutics

- ProQR

Global and United States Rare Disease Drug Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Rare Disease Drug Product Introduction
1.2 Market Segments
1.3 Key Rare Disease Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Rare Disease Drug Market Size Growth Rate by Type
1.4.2 Above 1‰
1.4.3 0.65‰~1‰
1.4.4 Below 0.1‰
1.5 Market by Application
1.5.1 Global Rare Disease Drug Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Speciality Pharmacies
1.5.4 Retail pharmacies
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Rare Disease Drug Market Size, Estimates and Forecasts
2.1.1 Global Rare Disease Drug Revenue 2015-2026
2.1.2 Global Rare Disease Drug Sales 2015-2026
2.2 Global Rare Disease Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Rare Disease Drug Historical Market Size by Region (2015-2020)
2.3.1 Global Rare Disease Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Rare Disease Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Rare Disease Drug Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Rare Disease Drug Sales Forecast by Region (2021-2026)
2.4.2 Global Rare Disease Drug Revenue Forecast by Region (2021-2026)
3 Global Rare Disease Drug Competitor Landscape by Players
3.1 Global Top Rare Disease Drug Sales by Manufacturers
3.1.1 Global Rare Disease Drug Sales by Manufacturers (2015-2020)
3.1.2 Global Rare Disease Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Global Rare Disease Drug Manufacturers by Revenue
3.2.1 Global Rare Disease Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global Rare Disease Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Rare Disease Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Rare Disease Drug Revenue in 2019
3.2.5 Global Rare Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Rare Disease Drug Price by Manufacturers
3.4 Global Rare Disease Drug Manufacturing Base Distribution, Product Types
3.4.1 Rare Disease Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Rare Disease Drug Product Type
3.4.3 Date of International Manufacturers Enter into Rare Disease Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Rare Disease Drug Market Size by Type (2015-2020)
4.1.1 Global Rare Disease Drug Sales by Type (2015-2020)
4.1.2 Global Rare Disease Drug Revenue by Type (2015-2020)
4.1.3 Rare Disease Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Rare Disease Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Rare Disease Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Rare Disease Drug Revenue Forecast by Type (2021-2026)
4.2.3 Rare Disease Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Rare Disease Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Rare Disease Drug Market Size by Application (2015-2020)
5.1.1 Global Rare Disease Drug Sales by Application (2015-2020)
5.1.2 Global Rare Disease Drug Revenue by Application (2015-2020)
5.1.3 Rare Disease Drug Price by Application (2015-2020)
5.2 Rare Disease Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Rare Disease Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Rare Disease Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Rare Disease Drug Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Rare Disease Drug Market Size YoY Growth 2015-2026
6.1.1 United States Rare Disease Drug Sales YoY Growth 2015-2026
6.1.2 United States Rare Disease Drug Revenue YoY Growth 2015-2026
6.1.3 United States Rare Disease Drug Market Share in Global Market 2015-2026
6.2 United States Rare Disease Drug Market Size by Players (International and Local Players)
6.2.1 United States Top Rare Disease Drug Players by Sales (2015-2020)
6.2.2 United States Top Rare Disease Drug Players by Revenue (2015-2020)
6.3 United States Rare Disease Drug Historic Market Review by Type (2015-2020)
6.3.1 United States Rare Disease Drug Sales Market Share by Type (2015-2020)
6.3.2 United States Rare Disease Drug Revenue Market Share by Type (2015-2020)
6.3.3 United States Rare Disease Drug Price by Type (2015-2020)
6.4 United States Rare Disease Drug Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Rare Disease Drug Sales Forecast by Type (2021-2026)
6.4.2 United States Rare Disease Drug Revenue Forecast by Type (2021-2026)
6.4.3 United States Rare Disease Drug Price Forecast by Type (2021-2026)
6.5 United States Rare Disease Drug Historic Market Review by Application (2015-2020)
6.5.1 United States Rare Disease Drug Sales Market Share by Application (2015-2020)
6.5.2 United States Rare Disease Drug Revenue Market Share by Application (2015-2020)
6.5.3 United States Rare Disease Drug Price by Application (2015-2020)
6.6 United States Rare Disease Drug Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Rare Disease Drug Sales Forecast by Application (2021-2026)
6.6.2 United States Rare Disease Drug Revenue Forecast by Application (2021-2026)
6.6.3 United States Rare Disease Drug Price Forecast by Application (2021-2026)
7 North America
7.1 North America Rare Disease Drug Market Size YoY Growth 2015-2026
7.2 North America Rare Disease Drug Market Facts & Figures by Country
7.2.1 North America Rare Disease Drug Sales by Country (2015-2020)
7.2.2 North America Rare Disease Drug Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Rare Disease Drug Market Size YoY Growth 2015-2026
8.2 Europe Rare Disease Drug Market Facts & Figures by Country
8.2.1 Europe Rare Disease Drug Sales by Country
8.2.2 Europe Rare Disease Drug Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Rare Disease Drug Market Size YoY Growth 2015-2026
9.2 Asia Pacific Rare Disease Drug Market Facts & Figures by Country
9.2.1 Asia Pacific Rare Disease Drug Sales by Region (2015-2020)
9.2.2 Asia Pacific Rare Disease Drug Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Rare Disease Drug Market Size YoY Growth 2015-2026
10.2 Latin America Rare Disease Drug Market Facts & Figures by Country
10.2.1 Latin America Rare Disease Drug Sales by Country
10.2.2 Latin America Rare Disease Drug Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Rare Disease Drug Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Rare Disease Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Rare Disease Drug Sales by Country
11.2.2 Middle East and Africa Rare Disease Drug Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Novartis AG
12.1.1 Novartis AG Corporation Information
12.1.2 Novartis AG Description and Business Overview
12.1.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novartis AG Rare Disease Drug Products Offered
12.1.5 Novartis AG Recent Development
12.2 Bristol-Myers Squibb Company
12.2.1 Bristol-Myers Squibb Company Corporation Information
12.2.2 Bristol-Myers Squibb Company Description and Business Overview
12.2.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Bristol-Myers Squibb Company Rare Disease Drug Products Offered
12.2.5 Bristol-Myers Squibb Company Recent Development
12.3 Celgene Corporation
12.3.1 Celgene Corporation Corporation Information
12.3.2 Celgene Corporation Description and Business Overview
12.3.3 Celgene Corporation Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Celgene Corporation Rare Disease Drug Products Offered
12.3.5 Celgene Corporation Recent Development
12.4 F. Hoffmann-La Roche Ltd.
12.4.1 F. Hoffmann-La Roche Ltd. Corporation Information
12.4.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
12.4.3 F. Hoffmann-La Roche Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.4.4 F. Hoffmann-La Roche Ltd. Rare Disease Drug Products Offered
12.4.5 F. Hoffmann-La Roche Ltd. Recent Development
12.5 Pfizer, Inc.
12.5.1 Pfizer, Inc. Corporation Information
12.5.2 Pfizer, Inc. Description and Business Overview
12.5.3 Pfizer, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Pfizer, Inc. Rare Disease Drug Products Offered
12.5.5 Pfizer, Inc. Recent Development
12.6 Sanofi S.A.
12.6.1 Sanofi S.A. Corporation Information
12.6.2 Sanofi S.A. Description and Business Overview
12.6.3 Sanofi S.A. Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Sanofi S.A. Rare Disease Drug Products Offered
12.6.5 Sanofi S.A. Recent Development
12.7 Alexion Pharmaceuticals, Inc.
12.7.1 Alexion Pharmaceuticals, Inc. Corporation Information
12.7.2 Alexion Pharmaceuticals, Inc. Description and Business Overview
12.7.3 Alexion Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Alexion Pharmaceuticals, Inc. Rare Disease Drug Products Offered
12.7.5 Alexion Pharmaceuticals, Inc. Recent Development
12.8 Eli Lilly and Company
12.8.1 Eli Lilly and Company Corporation Information
12.8.2 Eli Lilly and Company Description and Business Overview
12.8.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Eli Lilly and Company Rare Disease Drug Products Offered
12.8.5 Eli Lilly and Company Recent Development
12.9 Novo Nordisk A/S
12.9.1 Novo Nordisk A/S Corporation Information
12.9.2 Novo Nordisk A/S Description and Business Overview
12.9.3 Novo Nordisk A/S Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Novo Nordisk A/S Rare Disease Drug Products Offered
12.9.5 Novo Nordisk A/S Recent Development
12.10 AstraZeneca
12.10.1 AstraZeneca Corporation Information
12.10.2 AstraZeneca Description and Business Overview
12.10.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
12.10.4 AstraZeneca Rare Disease Drug Products Offered
12.10.5 AstraZeneca Recent Development
12.11 Novartis AG
12.11.1 Novartis AG Corporation Information
12.11.2 Novartis AG Description and Business Overview
12.11.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Novartis AG Rare Disease Drug Products Offered
12.11.5 Novartis AG Recent Development
12.12 Daiichi Sankyo Company Limited
12.12.1 Daiichi Sankyo Company Limited Corporation Information
12.12.2 Daiichi Sankyo Company Limited Description and Business Overview
12.12.3 Daiichi Sankyo Company Limited Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Daiichi Sankyo Company Limited Products Offered
12.12.5 Daiichi Sankyo Company Limited Recent Development
12.13 Bayer AG
12.13.1 Bayer AG Corporation Information
12.13.2 Bayer AG Description and Business Overview
12.13.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Bayer AG Products Offered
12.13.5 Bayer AG Recent Development
12.14 GlaxoSmithKline
12.14.1 GlaxoSmithKline Corporation Information
12.14.2 GlaxoSmithKline Description and Business Overview
12.14.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.14.4 GlaxoSmithKline Products Offered
12.14.5 GlaxoSmithKline Recent Development
12.15 Merck & Co., Inc.
12.15.1 Merck & Co., Inc. Corporation Information
12.15.2 Merck & Co., Inc. Description and Business Overview
12.15.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Merck & Co., Inc. Products Offered
12.15.5 Merck & Co., Inc. Recent Development
12.16 Johnson & Johnson
12.16.1 Johnson & Johnson Corporation Information
12.16.2 Johnson & Johnson Description and Business Overview
12.16.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Johnson & Johnson Products Offered
12.16.5 Johnson & Johnson Recent Development
12.17 Biogen, Inc.
12.17.1 Biogen, Inc. Corporation Information
12.17.2 Biogen, Inc. Description and Business Overview
12.17.3 Biogen, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Biogen, Inc. Products Offered
12.17.5 Biogen, Inc. Recent Development
12.18 Takeda
12.18.1 Takeda Corporation Information
12.18.2 Takeda Description and Business Overview
12.18.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Takeda Products Offered
12.18.5 Takeda Recent Development
12.19 Amgen, Inc.
12.19.1 Amgen, Inc. Corporation Information
12.19.2 Amgen, Inc. Description and Business Overview
12.19.3 Amgen, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Amgen, Inc. Products Offered
12.19.5 Amgen, Inc. Recent Development
12.20 Deciphera
12.20.1 Deciphera Corporation Information
12.20.2 Deciphera Description and Business Overview
12.20.3 Deciphera Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Deciphera Products Offered
12.20.5 Deciphera Recent Development
12.21 Atara Biotherapeutics
12.21.1 Atara Biotherapeutics Corporation Information
12.21.2 Atara Biotherapeutics Description and Business Overview
12.21.3 Atara Biotherapeutics Sales, Revenue and Gross Margin (2015-2020)
12.21.4 Atara Biotherapeutics Products Offered
12.21.5 Atara Biotherapeutics Recent Development
12.22 ProQR
12.22.1 ProQR Corporation Information
12.22.2 ProQR Description and Business Overview
12.22.3 ProQR Sales, Revenue and Gross Margin (2015-2020)
12.22.4 ProQR Products Offered
12.22.5 ProQR Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Rare Disease Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Rare Disease Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Rare Disease Drug Market Segments
Table 2. Ranking of Global Top Rare Disease Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Rare Disease Drug Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Above 1‰
Table 5. Major Manufacturers of 0.65‰?1‰
Table 6. Major Manufacturers of Below 0.1‰
Table 7. Global Rare Disease Drug Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 8. Global Rare Disease Drug Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 9. Global Rare Disease Drug Sales by Regions 2015-2020 (K Doses)
Table 10. Global Rare Disease Drug Sales Market Share by Regions (2015-2020)
Table 11. Global Rare Disease Drug Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Rare Disease Drug Sales Forecast by Region (2021-2026) (K Doses)
Table 13. Global Rare Disease Drug Sales by Manufacturers (2015-2020) (K Doses)
Table 14. Global Rare Disease Drug Sales Share by Manufacturers (2015-2020)
Table 15. Global Rare Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Rare Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rare Disease Drug as of 2019)
Table 17. Rare Disease Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Rare Disease Drug Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Rare Disease Drug Price (2015-2020) (USD/Dose)
Table 20. Rare Disease Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Rare Disease Drug Product Type
Table 22. Date of International Manufacturers Enter into Rare Disease Drug Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Rare Disease Drug Sales by Type (2015-2020) (K Doses)
Table 25. Global Rare Disease Drug Sales Share by Type (2015-2020)
Table 26. Global Rare Disease Drug Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Rare Disease Drug Revenue Share by Type (2015-2020)
Table 28. Rare Disease Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 29. Global Rare Disease Drug Sales Share by Type (2021-2026)
Table 30. Global Rare Disease Drug Sales by Application (2015-2020) (K Doses)
Table 31. Global Rare Disease Drug Sales Share by Application (2015-2020)
Table 32. Global Rare Disease Drug Sales Share by Application (2021-2026)
Table 33. Global Rare Disease Drug Sales Market Share Forecast by Application (2021-2026)
Table 34. Global Rare Disease Drug Revenue by Application (2015-2020) (US$ Million)
Table 35. Global Rare Disease Drug Revenue Market Share Forecast by Application (2021-2026)
Table 36. United States Rare Disease Drug Sales (K Doses) of Key Companies (2015-2020)
Table 37. United States Rare Disease Drug Sales Share by Company (2015-2020)
Table 38. United States Rare Disease Drug Revenue (US$ Million) by Company (2015-2020)
Table 39. United States Rare Disease Drug Sales (K Doses) by Type (2015-2020)
Table 40. United States Rare Disease Drug Sales Share by Type (2015-2020)
Table 41. United States Rare Disease Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 42. United States Rare Disease Drug Price (K Doses) by Type (2015-2020)
Table 43. United States Rare Disease Drug Sales (K Doses) by Type (2021-2026)
Table 44. United States Rare Disease Drug Sales Share by Type (2021-2026)
Table 45. United States Rare Disease Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 46. United States Rare Disease Drug Revenue Share by Type (2021-2026)
Table 47. United States Rare Disease Drug Price (K Doses) by Type (2021-2026)
Table 48. United States Rare Disease Drug Sales (K Doses) by Application (2015-2020)
Table 49. United States Rare Disease Drug Sales Share by Application (2015-2020)
Table 50. United States Rare Disease Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 51. United States Rare Disease Drug Sales (K Doses) by Application (2021-2026)
Table 52. United States Rare Disease Drug Sales Share by Application (2021-2026)
Table 53. United States Rare Disease Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 54. United States Rare Disease Drug Revenue Share by Application (2021-2026)
Table 55. North America Rare Disease Drug Sales by Country (2015-2020) (K Doses)
Table 56. North America Rare Disease Drug Sales Market Share by Country (2015-2020)
Table 57. North America Rare Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 58. North America Rare Disease Drug Revenue Market Share by Country (2015-2020)
Table 59. Europe Rare Disease Drug Sales by Country (2015-2020) (K Doses)
Table 60. Europe Rare Disease Drug Sales Market Share by Country (2015-2020)
Table 61. Europe Rare Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 62. Europe Rare Disease Drug Revenue Market Share by Country (2015-2020)
Table 63. Asia Pacific Rare Disease Drug Sales by Region (2015-2020) (K Doses)
Table 64. Asia Pacific Rare Disease Drug Sales Market Share by Region (2015-2020)
Table 65. Asia Pacific Rare Disease Drug Revenue by Region (2015-2020) (US$ Million)
Table 66. Asia Pacific Rare Disease Drug Revenue Market Share by Region (2015-2020)
Table 67. Latin America Rare Disease Drug Sales by Country (2015-2020) (K Doses)
Table 68. Latin America Rare Disease Drug Sales Market Share by Country (2015-2020)
Table 69. Latin Americaa Rare Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 70. Latin America Rare Disease Drug Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Rare Disease Drug Sales by Country (2015-2020) (K Doses)
Table 72. Middle East and Africa Rare Disease Drug Sales Market Share by Country (2015-2020)
Table 73. Middle East and Africa Rare Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 74. Middle East and Africa Rare Disease Drug Revenue Market Share by Country (2015-2020)
Table 75. Novartis AG Corporation Information
Table 76. Novartis AG Description and Business Overview
Table 77. Novartis AG Rare Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 78. Novartis AG Rare Disease Drug Product
Table 79. Novartis AG Recent Development
Table 80. Bristol-Myers Squibb Company Corporation Information
Table 81. Bristol-Myers Squibb Company Description and Business Overview
Table 82. Bristol-Myers Squibb Company Rare Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Bristol-Myers Squibb Company Product
Table 84. Bristol-Myers Squibb Company Recent Development
Table 85. Celgene Corporation Corporation Information
Table 86. Celgene Corporation Description and Business Overview
Table 87. Celgene Corporation Rare Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. Celgene Corporation Product
Table 89. Celgene Corporation Recent Development
Table 90. F. Hoffmann-La Roche Ltd. Corporation Information
Table 91. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 92. F. Hoffmann-La Roche Ltd. Rare Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. F. Hoffmann-La Roche Ltd. Product
Table 94. F. Hoffmann-La Roche Ltd. Recent Development
Table 95. Pfizer, Inc. Corporation Information
Table 96. Pfizer, Inc. Description and Business Overview
Table 97. Pfizer, Inc. Rare Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. Pfizer, Inc. Product
Table 99. Pfizer, Inc. Recent Development
Table 100. Sanofi S.A. Corporation Information
Table 101. Sanofi S.A. Description and Business Overview
Table 102. Sanofi S.A. Rare Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. Sanofi S.A. Product
Table 104. Sanofi S.A. Recent Development
Table 105. Alexion Pharmaceuticals, Inc. Corporation Information
Table 106. Alexion Pharmaceuticals, Inc. Description and Business Overview
Table 107. Alexion Pharmaceuticals, Inc. Rare Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. Alexion Pharmaceuticals, Inc. Product
Table 109. Alexion Pharmaceuticals, Inc. Recent Development
Table 110. Eli Lilly and Company Corporation Information
Table 111. Eli Lilly and Company Description and Business Overview
Table 112. Eli Lilly and Company Rare Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 113. Eli Lilly and Company Product
Table 114. Eli Lilly and Company Recent Development
Table 115. Novo Nordisk A/S Corporation Information
Table 116. Novo Nordisk A/S Description and Business Overview
Table 117. Novo Nordisk A/S Rare Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 118. Novo Nordisk A/S Product
Table 119. Novo Nordisk A/S Recent Development
Table 120. AstraZeneca Corporation Information
Table 121. AstraZeneca Description and Business Overview
Table 122. AstraZeneca Rare Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 123. AstraZeneca Product
Table 124. AstraZeneca Recent Development
Table 125. Eisai Co., Ltd. Corporation Information
Table 126. Eisai Co., Ltd. Description and Business Overview
Table 127. Eisai Co., Ltd. Rare Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 128. Eisai Co., Ltd. Product
Table 129. Eisai Co., Ltd. Recent Development
Table 130. Daiichi Sankyo Company Limited Corporation Information
Table 131. Daiichi Sankyo Company Limited Description and Business Overview
Table 132. Daiichi Sankyo Company Limited Rare Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 133. Daiichi Sankyo Company Limited Product
Table 134. Daiichi Sankyo Company Limited Recent Development
Table 135. Bayer AG Corporation Information
Table 136. Bayer AG Description and Business Overview
Table 137. Bayer AG Rare Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 138. Bayer AG Product
Table 139. Bayer AG Recent Development
Table 140. GlaxoSmithKline Corporation Information
Table 141. GlaxoSmithKline Description and Business Overview
Table 142. GlaxoSmithKline Rare Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 143. GlaxoSmithKline Product
Table 144. GlaxoSmithKline Recent Development
Table 145. Merck & Co., Inc. Corporation Information
Table 146. Merck & Co., Inc. Description and Business Overview
Table 147. Merck & Co., Inc. Rare Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 148. Merck & Co., Inc. Product
Table 149. Merck & Co., Inc. Recent Development
Table 150. Johnson & Johnson Corporation Information
Table 151. Johnson & Johnson Description and Business Overview
Table 152. Johnson & Johnson Rare Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 153. Johnson & Johnson Product
Table 154. Johnson & Johnson Recent Development
Table 155. Biogen, Inc. Corporation Information
Table 156. Biogen, Inc. Description and Business Overview
Table 157. Biogen, Inc. Rare Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 158. Biogen, Inc. Product
Table 159. Biogen, Inc. Recent Development
Table 160. Takeda Corporation Information
Table 161. Takeda Description and Business Overview
Table 162. Takeda Rare Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 163. Takeda Product
Table 164. Takeda Recent Development
Table 165. Amgen, Inc. Corporation Information
Table 166. Amgen, Inc. Description and Business Overview
Table 167. Amgen, Inc. Rare Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 168. Amgen, Inc. Product
Table 169. Amgen, Inc. Recent Development
Table 170. Deciphera Corporation Information
Table 171. Deciphera Description and Business Overview
Table 172. Deciphera Rare Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 173. Deciphera Product
Table 174. Deciphera Recent Development
Table 175. Atara Biotherapeutics Corporation Information
Table 176. Atara Biotherapeutics Description and Business Overview
Table 177. Atara Biotherapeutics Rare Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 178. Atara Biotherapeutics Product
Table 179. Atara Biotherapeutics Recent Development
Table 180. ProQR Corporation Information
Table 181. ProQR Description and Business Overview
Table 182. ProQR Rare Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 183. ProQR Product
Table 184. ProQR Recent Development
Table 185. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 186. Key Challenges
Table 187. Market Risks
Table 188. Main Points Interviewed from Key Rare Disease Drug Players
Table 189. Rare Disease Drug Customers List
Table 190. Rare Disease Drug Distributors List
Table 191. Research Programs/Design for This Report
Table 192. Key Data Information from Secondary Sources
Table 193. Key Data Information from Primary Sources
List of Figures
Figure 1. Rare Disease Drug Product Picture
Figure 2. Global Rare Disease Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Above 1‰ Product Picture
Figure 4. 0.65‰?1‰ Product Picture
Figure 5. Below 0.1‰ Product Picture
Figure 6. Global Rare Disease Drug Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital Pharmacies
Figure 8. Speciality Pharmacies
Figure 9. Retail pharmacies
Figure 10. Others
Figure 11. Rare Disease Drug Report Years Considered
Figure 12. Global Rare Disease Drug Market Size 2015-2026 (US$ Million)
Figure 13. Global Rare Disease Drug Sales 2015-2026 (K Doses)
Figure 14. Global Rare Disease Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Rare Disease Drug Sales Market Share by Region (2015-2020)
Figure 16. Global Rare Disease Drug Sales Market Share by Region in 2019
Figure 17. Global Rare Disease Drug Revenue Market Share by Region (2015-2020)
Figure 18. Global Rare Disease Drug Revenue Market Share by Region in 2019
Figure 19. Global Rare Disease Drug Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Rare Disease Drug Revenue in 2019
Figure 21. Rare Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Rare Disease Drug Sales Market Share by Type (2015-2020)
Figure 23. Global Rare Disease Drug Sales Market Share by Type in 2019
Figure 24. Global Rare Disease Drug Revenue Market Share by Type (2015-2020)
Figure 25. Global Rare Disease Drug Revenue Market Share by Type in 2019
Figure 26. Global Rare Disease Drug Market Share by Price Range (2015-2020)
Figure 27. Global Rare Disease Drug Sales Market Share by Application (2015-2020)
Figure 28. Global Rare Disease Drug Sales Market Share by Application in 2019
Figure 29. Global Rare Disease Drug Revenue Market Share by Application (2015-2020)
Figure 30. Global Rare Disease Drug Revenue Market Share by Application in 2019
Figure 31. United States Rare Disease Drug Sales Growth Rate 2015-2026 (K Doses)
Figure 32. United States Rare Disease Drug Revenue Growth Rate 2015-2026 (US$ Million)
Figure 33. United States Rare Disease Drug Market Share in Global Market 2015-2026
Figure 34. United States 5 and 10 Largest Rare Disease Drug Players Market Share by Revenue in Rare Disease Drug in 2019
Figure 35. United States Rare Disease Drug Revenue Share by Type (2015-2020)
Figure 36. United States Rare Disease Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 37. United States Rare Disease Drug Revenue Share by Application (2015-2020)
Figure 38. United States Rare Disease Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 39. North America Rare Disease Drug Sales Growth Rate 2015-2020 (K Doses)
Figure 40. North America Rare Disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. North America Rare Disease Drug Sales Market Share by Country in 2019
Figure 42. North America Rare Disease Drug Revenue Market Share by Country in 2019
Figure 43. U.S. Rare Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 44. U.S. Rare Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Canada Rare Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 46. Canada Rare Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Europe Rare Disease Drug Sales G
  • Global and China Microcarrier Market Insights, Forecast to 2026
    Published: 23-Oct-2020        Price: US 3900 Onwards        Pages: 126
    Microcarrier market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Microcarrier market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Microcarrier market is segmented into - ......
  • Global and Japan Softgel Dietary Supplements Market Insights, Forecast to 2026
    Published: 23-Oct-2020        Price: US 3900 Onwards        Pages: 130
    Softgel Dietary Supplements market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Softgel Dietary Supplements market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Softgel Dietary S......
  • Global and China Organic Capsules Market Insights, Forecast to 2026
    Published: 23-Oct-2020        Price: US 3900 Onwards        Pages: 125
    Organic Capsules market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Organic Capsules market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Organic Capsules market is segmented in......
  • Global and United States Acid Resistant Capsules Market Insights, Forecast to 2026
    Published: 23-Oct-2020        Price: US 3900 Onwards        Pages: 125
    Acid Resistant Capsules market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Acid Resistant Capsules market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Acid Resistant Capsules m......
  • Global and China Liquid-filled Capsules Market Insights, Forecast to 2026
    Published: 23-Oct-2020        Price: US 3900 Onwards        Pages: 130
    Liquid-filled Capsules market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Liquid-filled Capsules market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Liquid-filled Capsules mark......
  • Global and United States Two-piece Empty Hard Capsule Market Insights, Forecast to 2026
    Published: 23-Oct-2020        Price: US 3900 Onwards        Pages: 126
    Two-piece Empty Hard Capsule market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Two-piece Empty Hard Capsule market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Two-piece Empty......
  • Global and United States Tumor Necrosis Factor Alpha Inhibitors Market Insights, Forecast to 2026
    Published: 23-Oct-2020        Price: US 3900 Onwards        Pages: 146
    Tumor Necrosis Factor Alpha Inhibitors market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Tumor Necrosis Factor Alpha Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type,......
  • Global and United States Tuberculosis Vaccines Market Insights, Forecast to 2026
    Published: 23-Oct-2020        Price: US 3900 Onwards        Pages: 133
    Tuberculosis Vaccines market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Tuberculosis Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Tuberculosis Vaccines market ......
  • Global and China Orally Disintegrating Tablets Market Insights, Forecast to 2026
    Published: 23-Oct-2020        Price: US 3900 Onwards        Pages: 144
    Orally Disintegrating Tablets market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Orally Disintegrating Tablets market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Orally Disint......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs